Tag: Onego Bio

“Egg-cellent” idea: Onego Bio submits GRAS notification for chicken-free albumen

“Egg-cellent” idea: Onego Bio submits GRAS notification for chicken-free albumen

December 23, 2024 |

In the US, Finnish food ingredient company Onego Bio has officially submitted its Generally Recognized as Safe notification to the U.S. Food and Drug Administration for Bioalbumen, a non-animal ovalbumin produced through precision fermentation using Trichoderma reesei. The move sets the stage for introduction of the first non-animal egg protein that mirrors the amino acid […]

Read More

Onego Bio raises $40 million for animal-free egg protein

Onego Bio raises $40 million for animal-free egg protein

April 8, 2024 |

In Finland, Onego Bio has completed a $40-million Series A funding round to drive commercialization and manufacturing of egg protein via precision fermentation. Founded in 2022 as a spinoff from VTT, Onego Bio’s Bioalbumen® is bioidentical to ovalbumin, the major protein in chicken egg white, and contains all essential amino acids. Onego says Bioalbumen also […]

Read More